Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects Under Fasting Conditions

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2014

Study Completion Date

May 31, 2014

Conditions

Primary HypogonadismHypogonadotropic Hypogonadism

Interventions

DRUG

Testosterone Topical Gel, 1.62% Metered Pump

DRUG

AndroGel (testosterone gel) 1.62% Metered-Dose Pump

Trial Locations (1)

Phase One Solutions, Inc., Miami Gardens